BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lara JF, Young SM, Velilla RE, Santoro EJ, Templeton SF. The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up. Cancer. 2003;98:2105-2113. [PMID: 14601079 DOI: 10.1002/cncr.11761] [Cited by in Crossref: 95] [Cited by in F6Publishing: 75] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 El-tamer M, Chun J, Gill M, Bassi D, Lee S, Hibshoosh H, Mansukhani M. Incidence and Clinical Significance of Lymph Node Metastasis Detected by Cytokeratin Immunohistochemical Staining in Ductal Carcinoma In Situ. Ann Surg Oncol 2005;12:254-9. [DOI: 10.1245/aso.2005.05.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 1] [Article Influence: 1.6] [Reference Citation Analysis]
2 Kanbayashi C, Iwata H. Current approach and future perspective for ductal carcinoma in situ of the breast. Jpn J Clin Oncol 2017;47:671-7. [PMID: 28486668 DOI: 10.1093/jjco/hyx059] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 7.5] [Reference Citation Analysis]
3 Shin YD, Kang G, Jang H, Choi YJ. Trends in Axillary Surgery for Treating Ductal Carcinoma In Situ: A Korean Population-based Study. J Breast Cancer 2021;24:49-62. [PMID: 33634620 DOI: 10.4048/jbc.2021.24.e10] [Reference Citation Analysis]
4 Ko EY, Han BK, Shin JH, Kang SS. Breast MRI for evaluating patients with metastatic axillary lymph node and initially negative mammography and sonography. Korean J Radiol 2007;8:382-9. [PMID: 17923780 DOI: 10.3348/kjr.2007.8.5.382] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
5 Nicholson S, Hanby A, Clements K, Kearins O, Lawrence G, Dodwell D, Bishop H, Thompson A. Variations in the management of the axilla in screen-detected Ductal Carcinoma In Situ: Evidence from the UK NHS Breast Screening Programme audit of screen detected DCIS. European Journal of Surgical Oncology (EJSO) 2015;41:86-93. [DOI: 10.1016/j.ejso.2014.09.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
6 Patani N, Mokbel K. The clinical significance of sentinel lymph node micrometastasis in breast cancer. Breast Cancer Res Treat. 2009;114:393-402. [PMID: 18425678 DOI: 10.1007/s10549-008-0021-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
7 van Roozendaal LM, Goorts B, Klinkert M, Keymeulen KBMI, De Vries B, Strobbe LJA, Wauters CAP, van Riet YE, Degreef E, Rutgers EJT, Wesseling J, Smidt ML. Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy. Breast Cancer Res Treat 2016;156:517-25. [PMID: 27083179 DOI: 10.1007/s10549-016-3783-2] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 8.2] [Reference Citation Analysis]
8 Biganzoli E, Pedriali M, Querzoli P, Nenci I, Iacobelli S, Piantelli M, Alberti S. Sentinel Node and Bone Marrow Micrometastases and Nanometastases. Curr Breast Cancer Rep 2010;2:96-106. [DOI: 10.1007/s12609-010-0013-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
9 Collins CD. The sentinel node in breast cancer. Cancer Imaging 2008;8 Spec No A:S10-8. [PMID: 18852076 DOI: 10.1102/1470-7330.2008.9003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
10 Tunon-de-Lara C, Giard S, Buttarelli M, Blanchot J, Classe JM, Baron M, Monnier B, Houvenaeghel G. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy. Breast J. 2008;14:135-140. [PMID: 18315691 DOI: 10.1111/j.1524-4741.2007.00543.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
11 Huo L, Sneige N, Hunt KK, Albarracin CT, Lopez A, Resetkova E. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ. Cancer 2006;107:1760-8. [DOI: 10.1002/cncr.22216] [Cited by in Crossref: 73] [Cited by in F6Publishing: 56] [Article Influence: 4.9] [Reference Citation Analysis]
12 Salhab M, Patani N, Mokbel K. Sentinel lymph node micrometastasis in human breast cancer: an update. Surg Oncol. 2011;20:e195-e206. [PMID: 21788132 DOI: 10.1016/j.suronc.2011.06.006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
13 Fraile M, Gubern JM, Rull M, Julián FJ, Serra C, Llatjós M, Culell P, Puig P, Solà M, Vallejos V, Mariscal A, Janer J, Deulofeu P, Fusté F. Is it possible to refine the indication for sentinel node biopsy in high-risk ductal carcinoma in situ? Nuclear Medicine Communications 2006;27:785-9. [DOI: 10.1097/01.mnm.0000230074.39071.bf] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
14 Yonemori A, Kondo S, Matsuno Y, Ito T, Tanaka E, Hirano S. Para-Aortic Lymph Node Micrometastasis in Patients with Node-Negative Biliary Cancer. Dig Surg 2011;28:315-21. [DOI: 10.1159/000330784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
15 Bleiweiss IJ, Nagi CS, Jaffer S. Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma. J Clin Oncol 2006;24:2013-8. [PMID: 16606970 DOI: 10.1200/JCO.2005.04.7076] [Cited by in Crossref: 126] [Cited by in F6Publishing: 17] [Article Influence: 8.4] [Reference Citation Analysis]
16 Leidenius M, Salmenkivi K, von Smitten K, Heikkilä P. Tumour-positive sentinel node findings in patients with ductal carcinoma in situ. J Surg Oncol 2006;94:380-4. [DOI: 10.1002/jso.20581] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
17 Le Bouëdec G, de Lapasse C, Mishellany F, Chêne G, Michy T, Gimbergues P, Dauplat J. Cancer canalaire in situ du sein avec micro-invasion. Place du ganglion sentinelle. Gynécologie Obstétrique & Fertilité 2007;35:317-22. [DOI: 10.1016/j.gyobfe.2006.12.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
18 Bleiweiss IJ. Sentinel lymph nodes in breast cancer after 10 years: rethinking basic principles. The Lancet Oncology 2006;7:686-92. [DOI: 10.1016/s1470-2045(06)70796-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
19 Rutgers E. Guidelines to assure quality in breast cancer surgery. European Journal of Surgical Oncology (EJSO) 2005;31:568-76. [DOI: 10.1016/j.ejso.2005.02.008] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
20 Boler DE, Cabioglu N, Ince U, Esen G, Uras C. Sentinel Lymph Node Biopsy in Pure DCIS: Is It Necessary? ISRN Surg. 2012;2012:394095. [PMID: 22666611 DOI: 10.5402/2012/394095] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
21 Al-Ameer AY, Al Nefaie S, Al Johani B, Anwar I, Al Tweigeri T, Tulbah A, Alshabanah M, Al Malik O. Sentinel lymph node biopsy in clinically detected ductal carcinoma in situ. World J Clin Oncol 2016;7:258-64. [PMID: 27081649 DOI: 10.5306/wjco.v7.i2.258] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
22 Stuart KE, Houssami N, Taylor R, Hayen A, Boyages J. Long-term outcomes of ductal carcinoma in situ of the breast: a systematic review, meta-analysis and meta-regression analysis. BMC Cancer 2015;15:890. [PMID: 26555555 DOI: 10.1186/s12885-015-1904-7] [Cited by in Crossref: 48] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
23 Chin-lenn L, Mack LA, Temple W, Cherniak W, Quinn RR, Ravani P, Lewin AM, Quan ML. Predictors of Treatment with Mastectomy, Use of Sentinel Lymph Node Biopsy and Upstaging to Invasive Cancer in Patients Diagnosed with Breast Ductal Carcinoma In situ (DCIS) on Core Biopsy. Ann Surg Oncol 2014;21:66-73. [DOI: 10.1245/s10434-013-3239-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
24 Cody HS 3rd. Sentinel lymph node biopsy for DCIS: are we approaching consensus? Ann Surg Oncol 2007;14:2179-81. [PMID: 17265115 DOI: 10.1245/s10434-006-9300-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
25 O'Sullivan MJ, Morrow M. Ductal carcinoma in situ--current management. Surg Clin North Am 2007;87:333-51, viii. [PMID: 17498530 DOI: 10.1016/j.suc.2007.01.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
26 Wilkie C, White L, Dupont E, Cantor A, Cox CE. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. The American Journal of Surgery 2005;190:563-6. [DOI: 10.1016/j.amjsurg.2005.06.011] [Cited by in Crossref: 107] [Cited by in F6Publishing: 76] [Article Influence: 6.7] [Reference Citation Analysis]
27 James TA, Edge SB. Sentinel lymph node in breast cancer. Curr Opin Obstet Gynecol 2006;18:53-8. [PMID: 16493261 DOI: 10.1097/01.gco.0000192975.38858.4b] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
28 Charalampoudis P, Markopoulos C, Kovacs T. Controversies and recommendations regarding sentinel lymph node biopsy in primary breast cancer: A comprehensive review of current data. European Journal of Surgical Oncology 2018;44:5-14. [DOI: 10.1016/j.ejso.2017.10.215] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
29 Sakr R, Barranger E, Antoine M, Prugnolle H, Daraï E, Uzan S. Ductal carcinoma in situ: Value of sentinel lymph node biopsy. J Surg Oncol 2006;94:426-30. [DOI: 10.1002/jso.20578] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
30 Moore KH, Sweeney KJ, Wilson ME, Goldberg JI, Buchanan CL, Tan LK, Liberman L, Turner RR, Lagios MD, Cody Iii HS, Giuliano AE, Silverstein MJ, Van Zee KJ. Outcomes for Women With Ductal Carcinoma-in-Situ and a Positive Sentinel Node: A Multi-Institutional Audit. Ann Surg Oncol 2007;14:2911-7. [DOI: 10.1245/s10434-007-9414-8] [Cited by in Crossref: 57] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
31 Moran MS, Bai HX, Harris EE, Arthur DW, Bailey L, Bellon JR, Carey L, Goyal S, Halyard MY, Horst KC, MacDonald SM, Haffty BG; American College of Radiology Breast Expert Panel. ACR appropriateness criteria(®) ductal carcinoma in situ. Breast J 2012;18:8-15. [PMID: 22107336 DOI: 10.1111/j.1524-4741.2011.01197.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
32 Banys M, Gruber I, Krawczyk N, Becker S, Kurth R, Wallwiener D, Jakubowska J, Hoffmann J, Rothmund R, Staebler A, Fehm T. Hematogenous and lymphatic tumor cell dissemination may be detected in patients diagnosed with ductal carcinoma in situ of the breast. Breast Cancer Res Treat 2012;131:801-8. [DOI: 10.1007/s10549-011-1478-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
33 Shamliyan T, Wang SY, Virnig BA, Tuttle TM, Kane RL. Association between patient and tumor characteristics with clinical outcomes in women with ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010;2010:121-9. [PMID: 20956815 DOI: 10.1093/jncimonographs/lgq034] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 4.2] [Reference Citation Analysis]
34 Giard S, Chauvet M, Houpeau J, Baranzelli M, Carpentier P, Fournier C, Belkacemi Y, Bonneterre J. Le ganglion sentinelle sans curage systématique dans le cancer du sein : bilan d'une expérience de 1000 interventions. Gynécologie Obstétrique & Fertilité 2005;33:213-9. [DOI: 10.1016/j.gyobfe.2005.03.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
35 Ryan R, Tawfik O, Jensen RA, Anant S. Current Approaches to Diagnosis and Treatment of Ductal Carcinoma In Situ and Future Directions. Prog Mol Biol Transl Sci 2017;151:33-80. [PMID: 29096897 DOI: 10.1016/bs.pmbts.2017.08.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
36 Mabry H, Giuliano AE, Silverstein MJ. What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ? The American Journal of Surgery 2006;192:455-7. [DOI: 10.1016/j.amjsurg.2006.06.028] [Cited by in Crossref: 39] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
37 Schouten van der Velden A, Van Dijck J, Wobbes T. Variations in treatment of ductal carcinoma in situ of the breast: A population-based study in the East Netherlands. European Journal of Surgical Oncology (EJSO) 2007;33:424-9. [DOI: 10.1016/j.ejso.2006.09.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
38 Ansari B, Ogston SA, Purdie CA, Adamson DJ, Brown DC, Thompson AM. Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast. Br J Surg. 2008;95:547-554. [PMID: 18386775 DOI: 10.1002/bjs.6162] [Cited by in Crossref: 86] [Cited by in F6Publishing: 52] [Article Influence: 6.6] [Reference Citation Analysis]
39 Dominguez FJ, Golshan M, Black DM, Hughes KS, Gadd MA, Christian R, Lesnikoski BA, Specht M, Michaelson J, Smith BL. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ. Ann Surg Oncol. 2008;15:268-273. [PMID: 17891441 DOI: 10.1245/s10434-007-9610-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
40 Moran C, Kell M, Kerin M. The role of sentinel lymph node biopsy in ductal carcinoma in situ. European Journal of Surgical Oncology (EJSO) 2005;31:1105-11. [DOI: 10.1016/j.ejso.2005.06.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
41 Yonemori A, Kondo S, Matsuno Y, Ito T, Nakanishi Y, Miyamoto M, Tanaka E, Hirano S. Prognostic Impact of Regional Lymph Node Micrometastasis in Patients With Node-Negative Biliary Cancer. Annals of Surgery 2010;252:99-106. [DOI: 10.1097/sla.0b013e3181e33c0a] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
42 Griggs JJ, Sorbero ME, Ahrendt GM, Stark A, Heininger S, Gold HT, Schiffhauer LM, Dick AW. The pen and the scalpel: effect of diffusion of information on nonclinical variations in surgical treatment. Med Care 2009;47:749-57. [PMID: 19536033 DOI: 10.1097/MLR.0b013e31819748b3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
43 Alexander MC, Yankaskas BC, Biesemier KW. Association of stellate mammographic pattern with survival in small invasive breast tumors. AJR Am J Roentgenol 2006;187:29-37. [PMID: 16794151 DOI: 10.2214/AJR.04.0582] [Cited by in Crossref: 26] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
44 Lara JF, Young SM, Velilla RE, Santoro EJ, Templeton SF. The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up. Cancer. 2003;98:2105-2113. [PMID: 14601079 DOI: 10.1111/j.1524-4741.2007.00525.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
45 Taniguchi K, Tabata M, Iida T, Hori T, Yagi S, Uemoto S. Significance of lymph node micrometastasis in pN0 hilar bile duct carcinoma. Eur J Surg Oncol 2006;32:208-12. [PMID: 16377119 DOI: 10.1016/j.ejso.2005.11.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
46 Gervasoni JE Jr, Sbayi S, Cady B. Role of lymphadenectomy in surgical treatment of solid tumors: an update on the clinical data. Ann Surg Oncol 2007;14:2443-62. [PMID: 17597349 DOI: 10.1245/s10434-007-9360-5] [Cited by in Crossref: 48] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
47 Polom K, Murawa D, Murawa P. Flat epithelial atypia diagnosed on core needle biopsy-Clinical challenge. Rep Pract Oncol Radiother 2012;17:93-6. [PMID: 24377006 DOI: 10.1016/j.rpor.2011.12.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
48 Collins CD. The sentinel node in breast cancer: an update. Cancer Imaging 2005;5 Spec No A:S3-9. [PMID: 16361134 DOI: 10.1102/1470-7330.2005.0039] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
49 Aarsvold JN, Alazraki NP. Update on detection of sentinel lymph nodes in patients with breast cancer. Seminars in Nuclear Medicine 2005;35:116-28. [DOI: 10.1053/j.semnuclmed.2004.11.003] [Cited by in Crossref: 61] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
50 Yen TW, Hunt KK, Ross MI, Mirza NQ, Babiera GV, Meric-Bernstam F, Singletary SE, Symmans WF, Giordano SH, Feig BW. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg. 2005;200:516-526. [PMID: 15804465 DOI: 10.1016/j.jamcollsurg.2004.11.012] [Cited by in Crossref: 220] [Cited by in F6Publishing: 171] [Article Influence: 13.8] [Reference Citation Analysis]
51 Castellano I, Marchiò C, Tomatis M, Ponti A, Casella D, Bianchi S, Vezzosi V, Arisio R, Pietribiasi F, Frigerio A, Mano MP, Ricardi U, Allia E, Accortanzo V, Durando A, Bussolati G, Tot T, Sapino A. Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study. Mod Pathol 2010;23:260-9. [DOI: 10.1038/modpathol.2009.169] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
52 Sakata E, Shirai Y, Yokoyama N, Wakai T, Sakata J, Hatakeyama K. Clinical Significance of Lymph Node Micrometastasis in Ampullary Carcinoma. World J Surg 2006;30:985-91. [DOI: 10.1007/s00268-005-7985-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
53 Irvine T, Fentiman IS. Biology and treatment of ductal carcinoma in situ. Expert Review of Anticancer Therapy 2014;7:135-45. [DOI: 10.1586/14737140.7.2.135] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
54 James TA, Palis B, McCabe R, Pardo JA, Alapati A, Ukandu O, Serres SK, Zhang J, Mele A, Facktor M, Shulman LN. Evaluating the role of sentinel lymph node biopsy in patients with DCIS treated with breast conserving surgery. Am J Surg 2020;220:654-9. [PMID: 31964523 DOI: 10.1016/j.amjsurg.2020.01.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
55 Noguchi M. Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer. European Journal of Surgical Oncology (EJSO) 2008;34:129-34. [DOI: 10.1016/j.ejso.2007.03.026] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
56 van Deurzen CH, Hobbelink MG, van Hillegersberg R, van Diest PJ. Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review. Eur J Cancer 2007;43:993-1001. [PMID: 17300928 DOI: 10.1016/j.ejca.2007.01.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
57 Gray RJ, Pockaj BA, Conley CR. Sentinel Lymph Node Metastases Detected by Immunohistochemistry Only Do Not Mandate Complete Axillary Lymph Node Dissection in Breast Cancer. Ann Surg Oncol 2004;11:1056-60. [DOI: 10.1245/aso.2004.03.037] [Cited by in Crossref: 16] [Article Influence: 0.9] [Reference Citation Analysis]
58 Yonemori A, Kondo S, Matsuno Y, Ito T, Tanaka E, Hirano S. Prognostic impact of para-aortic lymph node micrometastasis in patients with regional node-positive biliary cancer. Br J Surg 2009;96:509-16. [PMID: 19358177 DOI: 10.1002/bjs.6585] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
59 Estévez LG, Álvarez I, Seguí MÁ, Muñoz M, Margelí M, Miró C, Rubio C, Lluch A, Tusquets I. Current perspectives of treatment of ductal carcinoma in situ. Cancer Treatment Reviews 2010;36:507-17. [DOI: 10.1016/j.ctrv.2010.03.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
60 van la Parra R, Ernst M, Barneveld P, Broekman J, Rutten M, Bosscha K. The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast. European Journal of Surgical Oncology (EJSO) 2008;34:631-5. [DOI: 10.1016/j.ejso.2007.08.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
61 Moran CJ, Kell MR, Flanagan FL, Kennedy M, Gorey TF, Kerin MJ. Role of sentinel lymph node biopsy in high-risk ductal carcinoma in situ patients. The American Journal of Surgery 2007;194:172-5. [DOI: 10.1016/j.amjsurg.2006.11.027] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
62 Fregatti P, Gipponi M, Diaz R, DE Rosa R, Murelli F, Depaoli F, Pitto F, Baldelli I, Zoppoli G, Ceppi M, Friedman D. The Role of Sentinel Lymph Node Biopsy in Patients With B5c Breast Cancer Diagnosis. In Vivo 2020;34:355-9. [PMID: 31882499 DOI: 10.21873/invivo.11781] [Reference Citation Analysis]
63 Bouzón Alejandro A, Iglesias López Á, Acea Nebril B, García Jiménez ML, Díaz Carballada CC, Varela Romero JR. Underestimation of invasive breast carcinoma in patients with initial diagnosis of ductal carcinoma in situ: Size matters. Cir Esp (Engl Ed) 2021:S0009-739X(20)30350-X. [PMID: 33541705 DOI: 10.1016/j.ciresp.2020.10.020] [Reference Citation Analysis]
64 Cappello F, David S, Rappa F, Bucchieri F, Marasa L, Bartolotta TE, Farina F, Zummo G. The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase. BMC Cancer. 2005;5:139. [PMID: 16253146 DOI: 10.1186/1471-2407-5-139] [Cited by in Crossref: 82] [Cited by in F6Publishing: 72] [Article Influence: 5.1] [Reference Citation Analysis]
65 Taniguchi K, Iida T, Hori T, Yagi S, Imai H, Shiraishi T, Uemoto S. Impact of lymph node micrometastasis in hilar bile duct carcinoma patients. World J Gastroenterol. 2006;12:2549-2555. [PMID: 16688800 DOI: 10.3748/wjg.v12.i16.2549] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
66 Shapiro-Wright HM, Julian TB. Sentinel lymph node biopsy and management of the axilla in ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010;2010:145-9. [PMID: 20956820 DOI: 10.1093/jncimonographs/lgq026] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
67 Wang L, Xia Y, Liu D, Zeng Y, Chang L, Li L, Hou Y, Ge L, Li W, Liu Z. Evaluating the efficacy of post-surgery adjuvant therapies used for ductal carcinoma in situ patients: a network meta-analysis. Oncotarget 2017;8:79257-69. [PMID: 29108304 DOI: 10.18632/oncotarget.17366] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
68 Weaver DL. Occult ?micrometastases? in ductal carcinoma in situ: Investigative implications for sentinel lymph node biopsy. Cancer 2003;98:2083-7. [DOI: 10.1002/cncr.11762] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
69 Katz A, Gage I, Evans S, Shaffer M, Fleury T, Smith FP, Flax R, Drogula C, Petrucci P, Magnant C. Sentinel lymph node positivity of patients with ductal carcinoma in situ or microinvasive breast cancer. The American Journal of Surgery 2006;191:761-6. [DOI: 10.1016/j.amjsurg.2006.01.019] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
70 Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up. Breast Cancer Res Treat 2008;109:405-16. [DOI: 10.1007/s10549-007-9668-7] [Cited by in Crossref: 91] [Cited by in F6Publishing: 58] [Article Influence: 6.5] [Reference Citation Analysis]
71 Zujewski J, Eng-wong J. Sentinel Lymph Node Biopsy in the Management of Ductal Carcinoma In Situ. Clinical Breast Cancer 2005;6:216-22. [DOI: 10.3816/cbc.2005.n.023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
72 Francis AM, Haugen CE, Grimes LM, Crow JR, Yi M, Mittendorf EA, Bedrosian I, Caudle AS, Babiera GV, Krishnamurthy S, Kuerer HM, Hunt KK. Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ? Ann Surg Oncol 2015;22:4270-9. [PMID: 25905585 DOI: 10.1245/s10434-015-4547-7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 7.3] [Reference Citation Analysis]
73 Osako T, Iwase T, Kimura K, Horii R, Akiyama F. Detection of occult invasion in ductal carcinoma in situ of the breast with sentinel node metastasis. Cancer Sci 2013;104:453-7. [PMID: 23281914 DOI: 10.1111/cas.12095] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
74 Tan JCC, Mccready DR, Easson AM, Leong WL. Role of Sentinel Lymph Node Biopsy in Ductal Carcinoma-in-situ Treated by Mastectomy. Ann Surg Oncol 2007;14:638-45. [DOI: 10.1245/s10434-006-9211-9] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
75 Ciocca RM, Morrow M. Ductal Carcinoma in Situ. In: Jatoi I, Kaufmann M, editors. Management of Breast Diseases. Berlin: Springer Berlin Heidelberg; 2010. pp. 201-25. [DOI: 10.1007/978-3-540-69743-5_12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]